By activating GLP-1 receptors, semaglutide suppresses appetite, reduces hunger cravings, and lowers calorie intake
doi: 10.1210/en.2006-0807
The peptide activates vascular endothelial growth factor receptor 2 (VEGFR2), triggering the VEGFR2-Akt-eNOS pathway, which promotes angiogenesis and improves blood flow to damaged tissue
One of the primary reasons individuals opt for B12 IM injections is to address B12 deficiency, which can lead to symptoms such as fatigue, weakness, difficulty concentrating, and neurological issues
It is important to distinguish between medically indicated B12 injections prescribed for deficiency and lipotropic injections, which are typically unlicensed medicines in the UK and lack robust clinical evidence for weight loss